Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-06-10 | 2021-09-30 | 140675 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-07-29 | 2021-11-05 | 143262 |
TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-05 | 2021-09-02 | 143722 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-02-17 | 2022-03-24 | 155137 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155174 |
TEVA-TENOFOVIR | 300MG | TABLET | Resolved | 2022-02-17 | 2022-12-15 | 155186 |
TEVA-CLOPIDOGREL | 300MG | TABLET | Resolved | 2022-04-28 | 2022-06-17 | 159587 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-12 | 2022-11-12 | 160432 |
TEVA-QUININE | 300MG | CAPSULE | Resolved | 2022-06-16 | 2022-12-08 | 162864 |
TEVA-DILTIAZEM XC | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-16 | 2023-04-28 | 184925 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-27 | 2023-06-09 | 190728 |
TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-08 | 2024-04-11 | 194138 |
TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195609 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-06-26 | 2023-07-06 | 196427 |
TEVA-DILTIAZEM XC | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-21 | 2024-01-11 | 199717 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-07-27 | 2023-10-12 | 200240 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-09 | 2023-12-07 | 209672 |
TEVA-CLOPIDOGREL | 300MG | TABLET | Actual shortage | 2023-12-07 | 2024-05-23 | 212720 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215746 |
TEVA-DILTIAZEM XC | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-18 | 2024-05-09 | 216466 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |